GLYCOPYRROLATE 2 MG TABLET

What it is

GLYCOPYRROLATE 2 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as glycopyrrolate.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Aurolife Pharma LLC, Rising Pharma Holdings, Inc. and Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

FDA lists it under 2 Established Pharmacologic Classes: Anticholinergic and Cholinergic Muscarinic Antagonist.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4.44 for 30 tablets (30 × $0.14813 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · Why 30 tablets · NADAC explanation codes

The 8 labelers

Other strengths, forms and brands

4 other products in the NADAC file share the FDA nonproprietary name glycopyrrolate with GLYCOPYRROLATE 2 MG TABLET.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 8 NDCs’ NADAC prices is $0.14813 per EA filed.

Of the 23 other products in FDA’s Anticholinergic class priced per EA, 16 have a higher middle NADAC price and 7 a lower one. The one in the middle is SCOPOLAMINE 1 MG/3 DAY PATCH, at $4.33565 per EA filed (eff. 2026-09-23).

Of the 25 other products in FDA’s Cholinergic Muscarinic Antagonist class priced per EA, 18 have a higher middle NADAC price and 7 a lower one. The one in the middle is TOLTERODINE TART ER 2 MG CAP, at $0.2678 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.